Higher Titer Of Anti-Citrullinated Protein Antibodies In Biologic-Naive Rheumatoid Arthritis Patients Are Candidate Biomarkers To Predict Sensitivity Leading To Clinical Remission With Abatacept; Data From The Abroad Study.

被引：0

作者：

Fujii, Takao ^{[1
]}

Sekiguchi, Masahiro ^{[2
]}

Matsui, Kiyoshi ^{[2
]}

Kitano, Masayasu ^{[2
]}

Hashimoto, Motomu ^{[1
]}

Ohmura, Koichiro ^{[1
]}

Yamamoto, Aihiro ^{[3
]}

Nakahara, Hideko ^{[4
]}

Maeda, Keiji ^{[4
]}

Yokota, Akira ^{[5
]}

Miki, Kenji ^{[6
]}

Shimmyo, Naoki ^{[7
]}

Kuroiwa, Takanori ^{[8
]}

Murakami, Kosaku ^{[1
]}

Ozaki, Yoshio ^{[9
]}

Higami, Kenshi ^{[10
]}

Yoshii, Ichiro ^{[11
]}

Nozaki, Yuji ^{[12
]}

Ikawa, Takashi ^{[13
]}

Morita, Satoshi ^{[14
]}

Kawahito, Yutaka ^{[3
]}

Nishimoto, Norihiro ^{[15
]}

Mimori, Tsuneyo ^{[1
]}

Sano, Hajime ^{[2
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Kyoto, Japan

[2] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan

[3] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto, Japan

[4] NTT West Osaka Hosp, Osaka, Japan

[5] Yokota Clin Rheumatol, Osaka, Japan

[6] Amagasaki Cent Hosp, Amagasaki, Hyogo, Japan

[7] Kashiba Asahigaoka Hosp, Kashiba, Japan

[8] Yukioka Hosp, Osaka, Japan

[9] Kansai Med Univ, Hirakata Hosp, Hirakata, Osaka, Japan

[10] Higami Hosp, Nara, Japan

[11] Yoshii Hosp, Shimanto, Japan

[12] Kinki Univ, Fac Med, Sayama, Osaka, Japan

[13] Osaka Rehabil Hosp, Hannan, Japan

[14] Yokohama City Univ, Yokohama, Kanagawa, Japan

[15] Osaka Rheumatol Clin, Osaka, Japan

来源：

ARTHRITIS AND RHEUMATISM | 2013年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

465

引用

页码：S204 / S205

页数：2

共 13 条

[1] VERY HIGH TITER OF ANTI-CITRULLINATED PROTEIN ANTIBODIES IS ASSOCIATED WITH THE ACHIEVEMENT OF CLINICAL REMISSION BY ABATACEPT IN BIOLOGIC-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS (THE ABROAD STUDY)
Fujii, T.
Sekiguchi, M.
Matsui, K.
Kitano, M.
Hashimoto, M.
Ohmura, K.
Yamamoto, A.
Nakahara, H.
Maeda, K.
Yokota, A.
Miki, K.
Shimmyo, N.
Kuroiwa, T.
Murakami, K.
Ozaki, Y.
Higami, K.
Yoshii, I.
Nozaki, Y.
Ikawa, T.
Morita, S.
Kawahito, Y.
Nishimoto, N.
Mimori, T.
Sano, H.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 889 - 889
[2] Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study
Sekiguchi, Masahiro
Fujii, Takao
Matsui, Kiyoshi
Murakami, Kosaku
Morita, Satoshi
Ohmura, Koichiro
Kawahito, Yutaka
Nishimoto, Norihiro
Mimori, Tsuneyo
Sano, Hajime
JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) : 1974 - 1983
[3] PREDICTING FACTORS ASSOCIATED WITH SUSTAINED CLINICAL REMISSION BY ABATACEPT ARE DIFFERENT BETWEEN IN YOUNGER AND ELDERLY PATIENTS WITH BIOLOGIC-NAIVE RHEUMATOID ARTHRITIS (ABROAD STUDY)
Sekjguchi, M.
Fujii, T.
Kitano, M.
Matsui, K.
Hashimoto, H.
Yokota, A.
Miki, K.
Yamamoto, A.
Fujimoto, T.
Hidaka, T.
Shimmyo, N.
Maeda, K.
Kuroiwa, T.
Yoshii, I.
Murakami, K.
Ohmura, K.
Morita, S.
Kawahito, Y.
Nishimoto, N.
Mimori, T.
Sano, H.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1054 - 1054
[4] Treatment Responses and Their Predictors Of Abatacept In Biologic naive Patients With Rheumatoid Arthritis; Data Form Abroad Study.
Kawahito, Yutaka
Fujii, Takao
Yokota, Akira
Hashimoto, Hideo
Matsui, Kiyoshi
Miki, Kenji
Kitano, Masayasu
Shinmyo, Naoki
Yamamoto, Aihiro
Ohmura, Koichiro
Kuroiwa, Takanori
Hidaka, Toshihiko
Yoshii, Ichiro
Nakahara, Hideko
Fujimoto, Takashi
Murakami, Kosaku
Morita, Satoshi
Sekiguchi, Masahiro
Nishimoto, Norihiro
Mimori, Tsuneyo
Sano, Hajime
ARTHRITIS AND RHEUMATISM, 2013, 65 : S601 - S601
[5] TOCILIZUMAB IS ASSOCIATED WITH HIGHER CDAI/SDAI REMISSION IN BIOLOGIC-NAIVE RHEUMATOID ARTHRITIS PATIENTS - DATA FROM REUMA.PT
Romao, V.
Santos, M.
Polido-Pereira, J.
Duarte, C.
Nero, P.
Miguel, C.
Costa, J.
Pimentel-Santos, F.
Barcelos, F.
Costa, L.
Melo Gomes, J.
Pereira da Silva, J.
Branco, J.
Canas da Silva, J.
Da Silva, J.
Fonseca, J.
Canhao, H.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 71 - 72
[6] Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naive patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI)
Misaki, Kenta
Tamura, Naoto
Azuma, Takanori
Shinoda, Koichiro
Tanaka, Masao
Fujiwara, Hiroshi
Tsuboi, Hideki
Kasama, Tsuyoshi
Yoshimi, Ryusuke
Hanyu, Tadamasa
Kusaka, Yoshiaki
Hirao, Makoto
Onishi, Makoto
Uchino, Ayumi
Izumiyama, Tomomasa
Yang, Kwang-Seok
Ogawa, Noriyoshi
Matsui, Kiyoshi
Kurasawa, Kazuhiro
Kawaai, Satoshi
Yasuoka, Hidekata
Okumura, Noriaki
Ueda, Yo
Tanaka, Eiichi
Inoue, Eisuke
Tsuritani, Katsuki
Matsumoto, Shigeru
Yamanaka, Hisashi
Harigai, Masayoshi
MODERN RHEUMATOLOGY, 2024, 34 (02) : 297 - 306
[7] Greater remission rates in patients with early versus long-standing disease in biologic-naive rheumatoid arthritis patients treated with abatacept: a post hoc analysis of randomised clinical trial data
Yazici, Y.
Reed, D. Moniz
Klem, C.
Rosenblatt, L.
Wu, G.
Kremer, J. M.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (03) : 494 - 499
[8] The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years
Licia Maria Henrique da Mota
Leopoldo Luiz dos Santos Neto
Jozélio Freire de Carvalho
Ivânio Alves Pereira
Rufus Burlingame
Henri A. Ménard
Ieda Maria Magalhães Laurindo
Rheumatology International, 2012, 32 : 3807 - 3812
[9] The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years
Henrique da Mota, Licia Maria
dos Santos Neto, Leopoldo Luiz
de Carvalho, Jozelio Freire
Pereira, Ivanio Alves
Burlingame, Rufus
Menard, Henri A.
Magalhaes Laurindo, Ieda Maria
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (12) : 3807 - 3812
[10] Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial
Lend, Kristina
Lampa, Jon
Padyukov, Leonid
Hetland, Merete Lund
Heiberg, Marte Schrumpf
Nordstrom, Dan C.
Nurmohamed, Michael T.
Rudin, Anna
Ostergaard, Mikkel
Haavardsholm, Espen A.
Horslev-Petersen, Kim
Uhlig, Till
Sokka-Isler, Tuulikki
Gudbjornsson, Bjorn
Grondal, Gerdur
Frazzei, Giulia
Christiaans, Jeroen
Wolbink, Gertjan
Rispens, Theo
Twisk, Jos W. R.
van Vollenhoven, Ronald F.
ANNALS OF THE RHEUMATIC DISEASES, 2024,

← 1 2 →